Postural reflexes in patients on long-term neuroleptic medication

1991 ◽  
Vol 93 (2) ◽  
pp. 119-122 ◽  
Author(s):  
Dennis J. Beckley ◽  
Bastiaan R. Bloem ◽  
Jaswinder Singh ◽  
Michael P. Remler ◽  
Nancy S. Wolfe ◽  
...  
1997 ◽  
Vol 21 (5) ◽  
pp. 273-275 ◽  
Author(s):  
Nigel Eastwood ◽  
Robert Pugh

This study investigated the knowledge and attitude of 100 patients about their depot neuroleptic medication. Patients were well informed about their medication, particularly those seen in depot clinics. Most patients were content with service delivery but 48% did not realise that they had a choice about receiving their treatment. This aspect of patients' rights should be addressed and demands sensitive management in the case of depot refusers, or when assertive outreach is planned. We suggest that such issues should be incorporated into an educational programme and discussed with patients when they are relatively well.


1993 ◽  
Vol 44 (1) ◽  
pp. 71-73 ◽  
Author(s):  
Robertson Macpherson ◽  
Duncan B. Double ◽  
R. Paul Rowlands ◽  
Denise M. Harrison

1984 ◽  
Vol 14 (4) ◽  
pp. 891-897 ◽  
Author(s):  
Anthony H. Mann ◽  
Rachel Jenkins ◽  
Peter S. Cross ◽  
Barry J. Gurland

SynopsisA comparison of medication prescribed for elderly residents in long-term care institutions in London and New York shows that New York residents are prescribed more drugs. The contrast is sharpest for those suffering from dementia who are much more likely to receive neuroleptic medication than their counterparts in London. Analysis indicates that the differences may reflect the greater emphasis in New York on the nursing-medical model of care, rather than any differences between the residents themselves.


2019 ◽  
Vol 55 (2) ◽  
pp. 151-164 ◽  
Author(s):  
Jemima Thompson ◽  
Jacki L. Stansfeld ◽  
Ruth E. Cooper ◽  
Nicola Morant ◽  
Nadia E. Crellin ◽  
...  

Abstract Purpose Neuroleptic (antipsychotic) drugs reduce psychotic symptoms, but how they achieve these effects and how the drugs’ effects are experienced by people who take them are less well understood. The present study describes a synthesis of qualitative data about mental and behavioural alterations associated with taking neuroleptics and how these interact with symptoms of psychosis and people’s sense of self and agency. Methods Nine databases were searched to identify qualitative literature concerning experiences of taking neuroleptic medication. A thematic synthesis was conducted. Results Neuroleptics were commonly experienced as producing a distinctive state of lethargy, cognitive slowing, emotional blunting and reduced motivation, which impaired functioning but also had beneficial effects on symptoms of psychosis and some other symptoms (e.g. insomnia). For some people, symptom reduction helped restore a sense of normality and autonomy, but others experienced a loss of important aspects of their personality. Across studies, many people adopted a passive stance towards long-term medication, expressing a sense of resignation, endurance or loss of autonomy. Conclusions Neuroleptic drugs modify cognition, emotions and motivation. These effects may be associated with reducing the intensity and impact of symptoms, but also affect people’s sense of self and agency. Understanding how the effects of neuroleptics are experienced by those who take them is important in developing a more collaborative approach to drug treatment in psychosis and schizophrenia.


2001 ◽  
Vol 13 (2) ◽  
pp. 49-52
Author(s):  
Y. Kaneda ◽  
A. Fujii

SummaryObjective:The authors investigated plasma homovanillic acid (HVA) levels and noradrenaline (NA) in chronically medicated schizophrenic inpatients.Methods:The subjects were 55 inpatients who were diagnosed according to the DSM-IV criteria for schizophrenia. Nine normal subjects were compared to the patient group. Each patient gave informed consent for the research involved in this study. Psychiatric symptoms were assessed using the BPRS.Results:(1) The medicated schizophrenic inpatients had significantly greater plasma NA levels, and higher but nonsignificant plasma HVA levels than the normal subjects.(2) In patients, there was a positive but nonsignificant correlation between the plasma NA levels and positive symptomatology. In contrast, plasma HVA levels were not correlated with either positive or negative symptomatology.Conclusion:On the basis of these results, we hypothesize that, mainly because of their catecholaminergic dysfunction, there is an increase in plasma NA and a tendency for increased plasma HVA in patients with chronic schizophrenia, regardless of long-term neuroleptic medication.


1959 ◽  
Vol 196 (6) ◽  
pp. 1218-1223 ◽  
Author(s):  
James A. Miller ◽  
Faith S. Miller

Nearly all mice cooled to less than 1°C can be reanimated if first cooled slowly to less than 20°C in a sealed vessel of appropriate size. During this period the O2 content of the vessel falls to 6%, the CO2 increases to 11% and the humidity to saturation. An analysis shows that hypercapnia is chiefly responsible for the success of the method, though hypoxia and increased humidity also are beneficial. This holds whether the percentage of recoveries, time and temperature of recovery of postural reflexes, or incidence of hind leg weakness is used as an index of success. During resuscitation the animals received artificial respiration with 100% O2, 95% O2 + 5% CO2, 90% O2 + 10% CO2, or air. Comparisons of percentage of recoveries, long term survivals and uninjured hind legs show that 95% O2 + 5% CO2 gives the best results and 100% O2 the poorest. These findings demonstrate the benefits of CO2 in deep hypothermia.


1998 ◽  
Vol 15 (2) ◽  
pp. 70-72 ◽  
Author(s):  
Candida Graham ◽  
Syed Hasan Jawed

AbstractThis case report is of a young male with learning disability, who presented with long-term polydipsia and hyperphagia. The patient's polydipsia and hyperphagia showed a correlation with long-term use of neuroleptics for behavioural problems. Withdrawal of all neuroleptic medication resulted in an immediate improvement in both the polydipsia and hyperphagia leading to a complete resolution of both symptoms. While neuroleptics are a recognised cause of polydipsia, hyperphagia is less frequently described and we believe this to be the first report in which a patient is observed to have polydipsia and hyperphagia induced by neuroleptics. We discuss the possible aetiological mechanisms for both polydipsia and hyperphagia and conclude that the basic pathophysiology in our case appears to be a neuroleptic induced malfunction of the satiety centre due to blockage of dopamine receptors in the ventromedial hypothalamus.


1990 ◽  
Vol 157 (2) ◽  
pp. 293-293 ◽  
Author(s):  
D. K. Deshmukh ◽  
V. S. Joshi ◽  
M. R. Agarwal

A case of rabbit syndrome, a complication of long-term neuroleptic medication, is reported. It is important to differentiate it from tardive dyskinesia and continuous therapy with an antiparkinsonian agent may be required for control of symptoms of rabbit syndrome.


2002 ◽  
Vol 47 (2) ◽  
pp. 85-87 ◽  
Author(s):  
Rika Kuriwaka ◽  
Takao Mitsui ◽  
Soichiro Fujiwara ◽  
Yoshihiko Nishida ◽  
Toshio Matsumoto

1999 ◽  
Vol 23 (8) ◽  
pp. 467-470 ◽  
Author(s):  
R. Goldbeck ◽  
S. Tomlinson ◽  
J. Bouch

Aims and methodThis study examined the attitudes and knowledge of patients regarding their depot neuroleptic medication. All patients were attending a community mental health centre in Clydebank, Scotland.ResultsMany patients had limited knowledge of their medication, its benefits and side-effects as well as the rationale for its use. The biggest gaps were found in patients' knowledge of the long-term side-effects of their medication.Clinical implicationsOur findings raise doubts as to the capacity of some patients to give informed consent to their treatment. A number of steps are outlined in order to raise patients' standard of knowledge.


Sign in / Sign up

Export Citation Format

Share Document